Tracks outcomes of surgical ablation procedures for atrial fibrillation
Records real-world results of heart rhythm surgery devices used in people with atrial fibrillation.
Plain-language title generated from the registry record
Registry title: Tracking Results of Ablations to Combat AF Registry Generation 2
Key facts
- Where
- Halifax and Kitchener, CanadaSee the 2 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The registry is looking for adults who are scheduled to have, or have had, a heart ablation procedure for atrial fibrillation.
- Age
- 18 years or older, or of legal age to give informed consent under state and national law.
- Sex
- All sexes can join.
- Earlier treatment
- People who are scheduled to undergo a cardiac ablation procedure, or have already had one.
Main reasons for not taking part
- Other medical, social, or psychological conditions that, in the investigator's opinion, prevent proper consent or following the study plan
Read by machine on 9 November 2026.
Where in Canada
- Nova Scotia Health AuthorityHalifax, CanadaTaking people
- Waterloo Regional Health NetworkKitchener, CanadaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- AtriCure, Inc.
- Trial code
- NCT05111015
- Record updated
- 29 June 2026
- Original description
The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.Read full original descriptionShow less
Tracking Results of Ablations to Combat AF Registry Generation 2
The primary objective of the TRAC-AF Registry is to capture real-world safety and effectiveness data on AtriCure devices used to conduct open concomitant and/or hybrid ablation, and management of the LAA concomitant to a cardiac ablation.
Inclusion: Patient has been scheduled by physician(s) to undergo or has undergone cardiac ablation procedure(s); Patient is willing to provide informed consent; Patient whose age is 18 years or above, or of legal age to give informed consent specific to state and national law.
Exclusion: Other medical, social, or psychological conditions that in the opinion of the Investigator precludes the subject from appropriate consent or adherence to the protocol.